Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

British Journal of Dermatology, 04/26/2012

The present findings show that the combination of immunoadsorption (IA) and rituximab (Rtx) induces rapid clinical remission and long–term control in difficult–to–treat pemphigus.

Print Article Summary Cat 2 CME Report